论文部分内容阅读
Pàez-Ribes M, Allen E, Hudock J, Takeda T,Okuyama H, Vials F, Inoue M, Bergers G,Hanahan D, Casanovas O Cancer Cell 2009 Mar 3 15(3):220-31 Comments Changes Clinical Practice: Singular anti-angiogenicagents should not be prescribedto cancer patients, instead anti-angiogenicdrugs should routinely be used as part ofcombination therapy in order to impede thenegative effects of antiangiogenics, whichmay induce invasiveness of residual tumors.
Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vials F, Inoue M, Bergers G, Hanahan D, Casanovas O Cancer Cell 2009 Mar 3 15 (3): 220-31 Comments Changes Clinical Practice : Singular anti-angiogenic agents should not be prescribedto cancer patients, instead of-angiogenicdrugs should routinely be used as part ofcombination therapy in order to impede thenegative effects of antiangiogenics, whichmay induce invasiveness of residual tumors.